GlaxoSmithKline-Vir COVID-19 Antibody Drug Granted EUA In U.S.
The U.S. Food and Drug Administration has granted an emergency use authorization for a COVID-19 antibody drug made by GlaxoSmithKline (GSK,GSK.L) and Vir Biotechnology. Sotrovimab, an investigational monoclonal antibody therapy, … Read More